No Data
No Data
No Data
No Data
No Data
Pharmaceutical Juno-B (02126) issued approximately 1.231 million shares under the share award scheme
Pharmaceutical Juno-B (02126) announced that on April 2, 2024, approximately 120 will be issued under the share award scheme...
Zhitong FinanceApr 2 07:37 ET
JW (Cayman) Therapeutics Shrinks Loss in Fiscal 2023
JW (Cayman) Therapeutics (HKG:2126) recorded a narrower attributable loss for the year ended Dec. 31, 2023, of 768 million yuan from 846.1 million yuan during the year-ago period, a Tuesday filing on
MT NewswiresMar 20 08:44 ET
Read the 2023 results of Mingjuno-B (02126): Revenue increased 19.3% year-on-year, gross sales margin increased to 50.7%
On March 20, Pharmaceutical Juno-B (02126) announced its annual results for the year ended December 31, 2023.
Zhitong FinanceMar 20 05:22 ET
JW THERAP-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 AND CHANGE IN USE OF NET PROCEEDS FROM LISTING
Futu NewsMar 20 04:34 ET · Announcements
Pharmaceutical Juno-B (02126.HK) held a board meeting on March 20 to consider and approve annual results
Gelonghui, March 8, 丨 Pharmaceutical Juno-B (02126.HK) announced that the company would like to hold a board meeting on March 20, 2024 (Wednesday) to (i) consider and approve the Group's audited consolidated results for the year ended 31 December 2023 and their release; (ii) the proposed final dividend (if any); and (iii) address any other matters.
Gelonghui FinanceMar 8 03:55 ET
Gelonghui Announcements Selected (Hong Kong Stocks) | Honghai Hi-Tech Resources (00065.HK) Plans to Invest in Copper Mines in Laos
[Today's Focus] Honghai Hi-Tech Resources (00065.HK) announced that it intends to invest in the Lao copper mine, Honghai Hi-Tech Resources (00065.HK). On January 4, 2024, Hongyuan (a direct wholly-owned subsidiary of the company), the target company Laos Taishan Jiujiu Investment & Trade Co., Ltd. and the target company shareholders (including guarantors) signed the memorandum on the proposed investment in the target company's shares. According to the memorandum, during the exclusivity period, the target company shall not (and require its agents and advisors not to) directly or indirectly discuss the sale or transfer of any of the target company's shares or significant assets and copper mines with any third party
Gelonghui FinanceJan 4 10:09 ET
No Data
No Data